Insider sale
ACHILLES THERAPEUTICS PLC
$57.4K
65K shares
What this filing means
PEGGS KARL STUART DR plans to sell 65K shares of ACHILLES THERAPEUTICS PLC valued at approximately $57.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/1/2024ACC: 0001967940-24-000007
65K
Shares to sell
$57.4K
Approx. market value
30K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months4
Vested RSUs
Compensation
10/1/2020
4.50KVested RSUs
Compensation
7/1/2020
15.20KVested RSUs
Compensation
4/1/2020
9.17KVested RSU's
Compensation
1/1/2020
1.12KTotal acquired30K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/1/2020 | Vested RSUs Compensation | 4.50K | — |
7/1/2020 | Vested RSUs Compensation | 15.20K | — |
4/1/2020 | Vested RSUs Compensation | 9.17K | — |
1/1/2020 | Vested RSU's Compensation | 1.12K | — |
| Total | 30K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
16.39K
Market value
$13.8K
11/2/2023
—Completed
Units to sell
18.61K
Market value
$15.7K
11/1/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
30K
Market value
$27.9K
2/1/2024
Total
Units
65K
Value
$57.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/2/2023 | 16.39K | $13.8K | — | Completed |
11/1/2023 | 18.61K | $15.7K | — | Completed |
| Planned — Approximate Date | ||||
2/1/2024 | 30K | $27.9K | NASDAQ | Planned |
| Total | 65K | $57.4K | ||